Gandhinagar, India

Suryakant Navale

This inventor holds 1 USPTO granted patent. Top assignee: Torrent Pharmaceuticals Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suryakant Navale. Retrieved from https://idiyas.com/inventor/suryakant-navale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suryakant Navale: Innovator in Pharmaceutical Composition

Introduction: Suryakant Navale is a notable inventor based in Gandhinagar, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for diabetes treatment. His work is characterized by a focus on improving glycemic control in adults with type 2 diabetes mellitus.

Latest Patents: Suryakant Navale holds a patent for a pharmaceutical composition of alogliptin and metformin. This invention relates to a stable pharmaceutical composition comprising an intimate mixture of alogliptin and metformin, along with suitable pharmaceutically acceptable excipients. The formulation specifies that metformin is present in about 3.3 parts or more by weight relative to 100 parts by weight of the total weight of the part comprising alogliptin. The invention also encompasses various processes for preparing this pharmaceutical composition.

Career Highlights: Suryakant Navale is associated with Torrent Pharmaceuticals Limited, a leading company in the pharmaceutical industry. His work at Torrent Pharmaceuticals has allowed him to focus on innovative solutions for diabetes management.

Collaborations: Some of his notable coworkers include Jaya Abraham and Pradip Mukhopadhyay. Their collaboration has contributed to the advancement of pharmaceutical research and development within the company.

Conclusion: Suryakant Navale's contributions to pharmaceutical innovation, particularly in diabetes treatment, highlight his role as a key inventor in the industry. His patent for the composition of alogliptin and metformin showcases his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…